J M Smith CEO and leadership

Alan serves as a consultant and strategic advisor to Thomas H Lee partners on pharma, medical device, life science, supply chain, and technology investments. Previously, Alan served as CEO of J M Smith Corporation, a $3.0 billion business with full P&L responsibility for nine business units. J M Smith Corporation wholesales and distributes pharmaceutical products and is also a leader in providing technology solutions to its chain, retail pharmacy, and long term care customers. Alan restructured the company from nine business units to just two: Smith Technologies and Smith Drug Company which resulted in Smith Technologies being sold to Francisco Partners in April/2020.

Alan is an accomplished leader focused on commercial growth, innovation, and operational excellence in distribution, manufacturing, service, and technology. He has served in officer positions within healthcare, pharma, medical device, biotechnology, industrial, and internet e-commerce. Functionally, Alan has also been a CFO, Chief Procurement Officer, Group VP of Operations, and VP of Merchandising and Sales. A proven track record of increasing customer enthusiasm and shareholder value through developing strategic plans, building high performing organizations, and enhancing operational efficiency in both turn around and high growth situations.